McKesson headquarters in San Francisco. Photo Credit: David Tran Photo/Shutterstock.com
Pharmaceutical company McKesson Corp. and two of its subsidiaries engaged in a scheme to skim excess oncology drugs from prepackaged vials, a health care provider has alleged in a new complaint filed in Brooklyn federal court.
April 05, 2018 at 03:38 PM
1 minute read
Pharmaceutical company McKesson Corp. and two of its subsidiaries engaged in a scheme to skim excess oncology drugs from prepackaged vials, a health care provider has alleged in a new complaint filed in Brooklyn federal court.
Omni Healthcare, a Florida-based health care provider, filed the qui tam suit on behalf of the federal government, 30 state governments, the city governments of Chicago and New York City and the District of Columbia.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
